Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Argani

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The American Journal of Pathology|June 8, 2001
A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocationP Argani, A Hawkins, C A Griffin, et al.
The American Journal of Pathology|February 13, 2001
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defectsE Montgomery, M Goggins, S Zhou, et al.
Cancer Research|April 15, 2000
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progressionR E Wilentz, C A Iacobuzio-Donahue, P Argani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2009
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomasG Martignoni, M Pea, S Gobbo, et al.
The American Journal of Pathology|January 7, 2000
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivationR E Wilentz, G H Su, J L Dai, et al.
American Journal of Clinical Pathology|January 5, 2002
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile ductM Tascilar, G J Offerhaus, R Altink, et al.
Cancer|April 3, 2001
Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ductsP Argani, A Shaukat, M Kaushal, et al.
Oncogene|April 19, 2006
Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cellsB Karakas, A Weeraratna, A Abukhdeir, et al.
The American Journal of Pathology|September 12, 2000
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomasC A Iacobuzio-Donahue, D S Klimstra, N V Adsay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)P Argani, C Iacobuzio-Donahue, B Ryu, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|June 8, 2001
A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocationP Argani, A Hawkins, C A Griffin, et al.
The American Journal of Pathology|February 13, 2001
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defectsE Montgomery, M Goggins, S Zhou, et al.
Cancer Research|April 15, 2000
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progressionR E Wilentz, C A Iacobuzio-Donahue, P Argani, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2009
Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomasG Martignoni, M Pea, S Gobbo, et al.
The American Journal of Pathology|January 7, 2000
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivationR E Wilentz, G H Su, J L Dai, et al.
American Journal of Clinical Pathology|January 5, 2002
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile ductM Tascilar, G J Offerhaus, R Altink, et al.
Cancer|April 3, 2001
Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ductsP Argani, A Shaukat, M Kaushal, et al.
Oncogene|April 19, 2006
Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cellsB Karakas, A Weeraratna, A Abukhdeir, et al.
The American Journal of Pathology|September 12, 2000
Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomasC A Iacobuzio-Donahue, D S Klimstra, N V Adsay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)P Argani, C Iacobuzio-Donahue, B Ryu, et al.
Pageof 5